Events and Presentations

On this page you will find a list of important events and presentations by Evolva.

  • ASM Biodefense and Emerging Diseases and Research Meeting in Washington DC, USA. Presenting: “EV-035: a new compound series with broad spectrum antibiotic activity against Burkholderia pseudomallei and other select agent pathogens”

    Sunday, February 26, 2012 to Wednesday, February 29, 2012
  • SMI Conferences Superbugs & Superdrugs - A Focus on Antibacterials in London, UK. Presenting: “EV-035, new 2-pyridone-based broad-spectrum topoisomerase inhibitors with activity on quinolone-resistant strains”

    Monday, March 5, 2012 to Tuesday, March 6, 2012
  • Financial results 2011

    Thursday, March 22, 2012
  • CHIs 6th annual Antibacterial Drug Development in San Diego, USA. Presenting: “Safe drugs to kill bad bugs – Evolva´s novel topoisomerase inhibitors”

    Tuesday, April 17, 2012
  • Oxfords´s 13th Annual Drug Discovery and Development Leaders Summit in Zürich, Switzerland

    Monday, June 11, 2012 to Tuesday, June 12, 2012
  • ESC Congress 2012, Munich, Germany

    Saturday, August 25, 2012 to Wednesday, August 29, 2012

Contact Information

Evolva SA
Duggingerstrasse 23
CH-4153 Reinach
Switzerland
Tel: +41 61 485 2000
Fax: +41 61 485 2001
Evolva A/S
Lersoe Parkallé 42-44
DK-2100 Copenhagen OE
Denmark
Tel: +45 35 200 230
Fax: +45 35 200 231
Evolva Biotech Private Limited
401 - 405, 4th Floor
Ticel Bio Park Ltd
Taramani Road, Taramani
Chennai 600 113
Tamil Nadu, India
Tel: +91 44 4297 1050
Fax: +91 44 4297 1060
Evolva, Inc. (Evolva USA)
2440 Embarcadero Way
Palo Alto
CA 94303
USA
Tel: +1 650 856 2436
Fax: +1 650 856 7950

General Enquiries: info@evolva.com • Business Enquiries: busdev@evolva.com • India Enquiries: info_india@evolva.com